Release Date: 22/04/10 10:28 Summary: Myszkow Concession Update Price Sensitive: Yes Download Document 162.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%